Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 157

1.

Developmental changes in CSF hypocretin-1 (orexin-A) levels in normal and genetically narcoleptic Doberman pinschers.

John J, Wu MF, Maidment NT, Lam HA, Boehmer LN, Patton M, Siegel JM.

J Physiol. 2004 Oct 15;560(Pt 2):587-92. Epub 2004 Aug 12.

2.

Role of the hypocretin (orexin) receptor 2 (Hcrt-r2) in the regulation of hypocretin level and cataplexy.

Wu MF, Nienhuis R, Maidment N, Lam HA, Siegel JM.

J Neurosci. 2011 Apr 27;31(17):6305-10. doi: 10.1523/JNEUROSCI.0365-11.2011.

3.

Hypocretin receptor expression in canine and murine narcolepsy models and in hypocretin-ligand deficient human narcolepsy.

Mishima K, Fujiki N, Yoshida Y, Sakurai T, Honda M, Mignot E, Nishino S.

Sleep. 2008 Aug;31(8):1119-26.

4.

Narcolepsy without cataplexy: 2 subtypes based on CSF hypocretin-1/orexin-A findings.

Oka Y, Inoue Y, Kanbayashi T, Kuroda K, Miyamoto M, Miyamoto T, Ikeda A, Shimizu T, Hishikawa Y, Shibasaki H.

Sleep. 2006 Nov;29(11):1439-43.

PMID:
17162990
5.

HLA DQB1*06:02 negative narcolepsy with hypocretin/orexin deficiency.

Han F, Lin L, Schormair B, Pizza F, Plazzi G, Ollila HM, Nevsimalova S, Jennum P, Knudsen S, Winkelmann J, Coquillard C, Babrzadeh F, Strom TM, Wang C, Mindrinos M, Fernandez Vina M, Mignot E.

Sleep. 2014 Oct 1;37(10):1601-8. doi: 10.5665/sleep.4066.

6.

CSF hypocretin-1 levels and clinical profiles in narcolepsy and idiopathic CNS hypersomnia in Norway.

Heier MS, Evsiukova T, Vilming S, Gjerstad MD, Schrader H, Gautvik K.

Sleep. 2007 Aug;30(8):969-73.

7.

Predictors of hypocretin (orexin) deficiency in narcolepsy without cataplexy.

Andlauer O, Moore H 4th, Hong SC, Dauvilliers Y, Kanbayashi T, Nishino S, Han F, Silber MH, Rico T, Einen M, Kornum BR, Jennum P, Knudsen S, Nevsimalova S, Poli F, Plazzi G, Mignot E.

Sleep. 2012 Sep 1;35(9):1247-55F. doi: 10.5665/sleep.2080.

8.

Decreased CSF histamine in narcolepsy with and without low CSF hypocretin-1 in comparison to healthy controls.

Nishino S, Sakurai E, Nevsimalova S, Yoshida Y, Watanabe T, Yanai K, Mignot E.

Sleep. 2009 Feb;32(2):175-80.

9.

HLA-DQB1 allele and hypocretin in Korean narcoleptics with cataplexy.

Jeong JH, Hong SC, Shin YK, Han JH, Lee SP.

J Korean Med Sci. 2007 Feb;22(1):127-31.

10.

The development of hypocretin (orexin) deficiency in hypocretin/ataxin-3 transgenic rats.

Zhang S, Lin L, Kaur S, Thankachan S, Blanco-Centurion C, Yanagisawa M, Mignot E, Shiromani PJ.

Neuroscience. 2007 Aug 10;148(1):34-43. Epub 2007 Jul 6.

11.

Hypocretin levels in sporadic and familial cases of canine narcolepsy.

Ripley B, Fujiki N, Okura M, Mignot E, Nishino S.

Neurobiol Dis. 2001 Jun;8(3):525-34.

PMID:
11442359
12.
13.

Identification and functional analysis of mutations in the hypocretin (orexin) genes of narcoleptic canines.

Hungs M, Fan J, Lin L, Lin X, Maki RA, Mignot E.

Genome Res. 2001 Apr;11(4):531-9.

14.

CSF histamine contents in narcolepsy, idiopathic hypersomnia and obstructive sleep apnea syndrome.

Kanbayashi T, Kodama T, Kondo H, Satoh S, Inoue Y, Chiba S, Shimizu T, Nishino S.

Sleep. 2009 Feb;32(2):181-7.

15.

Hypocretin and human African trypanosomiasis.

Dauvilliers Y, Bisser S, Chapotot F, Vatunga G, Cespuglio R, Josenando T, Buguet A.

Sleep. 2008 Mar;31(3):348-54.

17.

CSF hypocretin-1 (orexin-A) concentrations in narcolepsy with and without cataplexy and idiopathic hypersomnia.

Kanbayashi T, Inoue Y, Chiba S, Aizawa R, Saito Y, Tsukamoto H, Fujii Y, Nishino S, Shimizu T.

J Sleep Res. 2002 Mar;11(1):91-3.

18.

[Comparative analysis of patients with narcolepsy-cataplexy, narcolepsy without cataplexy and idiopathic hypersomnia].

Martínez-Rodríguez JE, Iranzo A, Casamitjana R, Graus F, Santamaria J.

Med Clin (Barc). 2007 Mar 17;128(10):361-4. Spanish.

PMID:
17386240
19.

The narcoleptic borderland: a multimodal diagnostic approach including cerebrospinal fluid levels of hypocretin-1 (orexin A).

Bassetti C, Gugger M, Bischof M, Mathis J, Sturzenegger C, Werth E, Radanov B, Ripley B, Nishino S, Mignot E.

Sleep Med. 2003 Jan;4(1):7-12.

PMID:
14592354
20.

Undetectable levels of CSF hypocretin-1 (orexin-A) in two prepubertal boys with narcolepsy.

Tsukamoto H, Ishikawa T, Fujii Y, Fukumizu M, Sugai K, Kanbayashi T.

Neuropediatrics. 2002 Feb;33(1):51-2.

PMID:
11930279

Supplemental Content

Support Center